P
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- 8-K2.4 MBPhaseBio Pharmaceuticals IncAug 15, 4:02 PM ET·0001193125-24-201295
- 8-K6.5 MBPhaseBio Pharmaceuticals IncJul 12, 4:42 PM ET·0001193125-24-178615
- 8-K3.3 MBPhaseBio Pharmaceuticals IncMay 16, 4:28 PM ET·0001193125-24-140615
- 8-K6.1 MBPhaseBio Pharmaceuticals IncMar 12, 4:34 PM ET·0001193125-24-065935
- 8-K9.1 MBPhaseBio Pharmaceuticals IncNov 29, 4:55 PM ET·0001169245-23-000056
- 8-K158.3 KBPhaseBio Pharmaceuticals IncOct 3, 7:17 AM ET·0001169245-23-000052
- 8-K4.5 MBPhaseBio Pharmaceuticals IncSep 27, 8:52 AM ET·0001169245-23-000050
- 8-K8.9 MBPhaseBio Pharmaceuticals IncAug 25, 12:34 PM ET·0001169245-23-000047
- 8-K4.4 MBPhaseBio Pharmaceuticals IncJun 30, 4:21 PM ET·0001169245-23-000039
- 8-K4.7 MBPhaseBio Pharmaceuticals IncMay 30, 4:02 PM ET·0001169245-23-000035
Insiders
10- Arnold Susan ElizabethVP, Preclinical and Chem.
- ASTRAZENECA PLC10% Owner
- Ballance David JamesVP, Research and Sci. Affairs
- BARRETT M JAMES10% Owner
- BARRIS PETER J10% Owner
- BASKETT FOREST10% Owner
- Birchall JonathanChief Commercial Officer
- Burkhardt GlenVP, Human Resources
- Catalysta Ventures, LLC10% Owner
- Hanson KristopherVice President, Head of Legal
Tickers
No tickers on record
Addresses
business
1 GREAT VALLEY PARKWAY SUITE 30
MALVERN, PA, 19355
mailing
1 GREAT VALLEY PARKWAY SUITE 30
MALVERN, PA, 19355
Former Names
- Phase Biosciences Inc2008-04-23
- DT BIOSCIENCES INC2004-05-11